Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1997 Oct;10(4):742–780. doi: 10.1128/cmr.10.4.742

A primer on cytokines: sources, receptors, effects, and inducers.

J H Curfs 1, J F Meis 1, J A Hoogkamp-Korstanje 1
PMCID: PMC172943  PMID: 9336671

Abstract

Protection against pathogens is a prerequisite for survival of most organisms. To cope with this continuous challenge, complex defense mechanisms have evolved. The construction, adaptation, and maintenance of these mechanisms are under control of an extensive network of regulatory proteins called cytokines. A great number of cytokines have been described over the last 2 decades. This review consists of an overview of cytokines that are involved in immune responses and describes some historical and general aspects as well as prospective clinical applications. Major biological effects together with information on cytokine receptors, producers, inducers, and biochemical and molecular characteristics are listed in tables. In addition, some basic information is given on cytokine receptor signal transduction. Finally, the recent discoveries of cytokine receptors functioning as coreceptors in the pathogenesis of human immunodeficiency virus are summarized.

Full Text

The Full Text of this article is available as a PDF (1.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrus J. L., Jr, Chesky L., Chused T., Young K. R., Jr, McFarland P., August A., Brown E. J. Intracellular signaling events associated with the induction of proliferation of normal human B lymphocytes by two different antigenically related human B cell growth factors (high molecular weight B cell growth factor (HMW-BCGF) and the complement factor Bb). J Biol Chem. 1991 Feb 25;266(6):3702–3708. [PubMed] [Google Scholar]
  2. Ambrus J. L., Jr, Jurgensen C. H., Brown E. J., Fauci A. S. Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor. J Exp Med. 1985 Oct 1;162(4):1319–1335. doi: 10.1084/jem.162.4.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Appasamy P. M. Interleukin-7: biology and potential clinical applications. Cancer Invest. 1993;11(4):487–499. doi: 10.3109/07357909309018880. [DOI] [PubMed] [Google Scholar]
  4. Arai K. I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783–836. doi: 10.1146/annurev.bi.59.070190.004031. [DOI] [PubMed] [Google Scholar]
  5. Baird P. N., D'Andrea R. J., Goodall G. J. Cytokine receptor genes: structure, chromosomal location, and involvement in human disease. Leuk Lymphoma. 1995 Aug;18(5-6):373–383. doi: 10.3109/10428199509059635. [DOI] [PubMed] [Google Scholar]
  6. Bamford R. N., Grant A. J., Burton J. D., Peters C., Kurys G., Goldman C. K., Brennan J., Roessler E., Waldmann T. A. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4940–4944. doi: 10.1073/pnas.91.11.4940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Baron S., Tyring S. K., Fleischmann W. R., Jr, Coppenhaver D. H., Niesel D. W., Klimpel G. R., Stanton G. J., Hughes T. K. The interferons. Mechanisms of action and clinical applications. JAMA. 1991 Sep 11;266(10):1375–1383. doi: 10.1001/jama.266.10.1375. [DOI] [PubMed] [Google Scholar]
  8. Barton B. E. The biological effects of interleukin 6. Med Res Rev. 1996 Jan;16(1):87–109. doi: 10.1002/(SICI)1098-1128(199601)16:1<87::AID-MED3>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  9. Bazzoni F., Beutler B. How do tumor necrosis factor receptors work? J Inflamm. 1995;45(4):221–238. [PubMed] [Google Scholar]
  10. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996 Jun 27;334(26):1717–1725. doi: 10.1056/NEJM199606273342607. [DOI] [PubMed] [Google Scholar]
  11. Beagley K. W., Eldridge J. H., Lee F., Kiyono H., Everson M. P., Koopman W. J., Hirano T., Kishimoto T., McGhee J. R. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med. 1989 Jun 1;169(6):2133–2148. doi: 10.1084/jem.169.6.2133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bendtzen K. Cytokines and natural regulators of cytokines. Immunol Lett. 1994 Dec;43(1-2):111–123. doi: 10.1016/0165-2478(94)00153-7. [DOI] [PubMed] [Google Scholar]
  13. Bendtzen K., Hansen M. B., Ross C., Poulsen L. K., Svenson M. Cytokines and autoantibodies to cytokines. Stem Cells. 1995 May;13(3):206–222. doi: 10.1002/stem.5530130303. [DOI] [PubMed] [Google Scholar]
  14. Berg D. J., Kühn R., Rajewsky K., Müller W., Menon S., Davidson N., Grünig G., Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995 Nov;96(5):2339–2347. doi: 10.1172/JCI118290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Beutler B., Cerami A. The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol. 1989;7:625–655. doi: 10.1146/annurev.iy.07.040189.003205. [DOI] [PubMed] [Google Scholar]
  16. Biron C. A., Gazzinelli R. T. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr Opin Immunol. 1995 Aug;7(4):485–496. doi: 10.1016/0952-7915(95)80093-x. [DOI] [PubMed] [Google Scholar]
  17. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996 Aug 29;382(6594):829–833. doi: 10.1038/382829a0. [DOI] [PubMed] [Google Scholar]
  18. Borger P., Kauffman H. F., Postma D. S., Vellenga E. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J Immunol. 1996 Feb 15;156(4):1333–1338. [PubMed] [Google Scholar]
  19. Borish L., Rosenbaum R., Albury L., Clark S. Activation of neutrophils by recombinant interleukin 6. Cell Immunol. 1989 Jul;121(2):280–289. doi: 10.1016/0008-8749(89)90026-9. [DOI] [PubMed] [Google Scholar]
  20. Bradding P. Human mast cell cytokines. Clin Exp Allergy. 1996 Jan;26(1):13–19. doi: 10.1111/j.1365-2222.1996.tb00051.x. [DOI] [PubMed] [Google Scholar]
  21. Bromander A. K., Ekman L., Kopf M., Nedrud J. G., Lycke N. Y. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J Immunol. 1996 Jun 1;156(11):4290–4297. [PubMed] [Google Scholar]
  22. Brooks J. W., Mizel S. B. Interleukin-1 signal transduction. Eur Cytokine Netw. 1994 Nov-Dec;5(6):547–561. [PubMed] [Google Scholar]
  23. Brouckaert P., Libert C., Everaerdt B., Takahashi N., Cauwels A., Fiers W. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology. 1993 Apr;187(3-5):317–329. doi: 10.1016/S0171-2985(11)80347-5. [DOI] [PubMed] [Google Scholar]
  24. Brown P. M., Tagari P., Rowan K. R., Yu V. L., O'Neill G. P., Middaugh C. R., Sanyal G., Ford-Hutchinson A. W., Nicholson D. W. Epitope-labeled soluble human interleukin-5 (IL-5) receptors. Affinity cross-link labeling, IL-5 binding, and biological activity. J Biol Chem. 1995 Dec 8;270(49):29236–29243. doi: 10.1074/jbc.270.49.29236. [DOI] [PubMed] [Google Scholar]
  25. Broxmeyer H. E., Cooper S., Hague N., Benninger L., Sarris A., Cornetta K., Vadhan-Raj S., Hendrie P., Mantel C. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Ann Hematol. 1995 Nov;71(5):235–246. doi: 10.1007/BF01744373. [DOI] [PubMed] [Google Scholar]
  26. Bruce A. G., Linsley P. S., Rose T. M. Oncostatin M. Prog Growth Factor Res. 1992;4(2):157–170. doi: 10.1016/0955-2235(92)90029-h. [DOI] [PubMed] [Google Scholar]
  27. Brunda M. J. Interleukin-12. J Leukoc Biol. 1994 Feb;55(2):280–288. doi: 10.1002/jlb.55.2.280. [DOI] [PubMed] [Google Scholar]
  28. Butterworth A. E. Cell-mediated damage to helminths. Adv Parasitol. 1984;23:143–235. doi: 10.1016/s0065-308x(08)60287-0. [DOI] [PubMed] [Google Scholar]
  29. Carson W. E., Ross M. E., Baiocchi R. A., Marien M. J., Boiani N., Grabstein K., Caligiuri M. A. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest. 1995 Dec;96(6):2578–2582. doi: 10.1172/JCI118321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Center D. M., Kornfeld H., Cruikshank W. W. Interleukin 16 and its function as a CD4 ligand. Immunol Today. 1996 Oct;17(10):476–481. doi: 10.1016/0167-5699(96)10052-i. [DOI] [PubMed] [Google Scholar]
  31. Chazen G. D., Pereira G. M., LeGros G., Gillis S., Shevach E. M. Interleukin 7 is a T-cell growth factor. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5923–5927. doi: 10.1073/pnas.86.15.5923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Chen C. C., Manning A. M. TGF-beta 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine. 1996 Jan;8(1):58–65. doi: 10.1006/cyto.1995.0008. [DOI] [PubMed] [Google Scholar]
  33. Clark-Lewis I., Kim K. S., Rajarathnam K., Gong J. H., Dewald B., Moser B., Baggiolini M., Sykes B. D. Structure-activity relationships of chemokines. J Leukoc Biol. 1995 May;57(5):703–711. doi: 10.1002/jlb.57.5.703. [DOI] [PubMed] [Google Scholar]
  34. Clayberger C., Luna-Fineman S., Lee J. E., Pillai A., Campbell M., Levy R., Krensky A. M. Interleukin 3 is a growth factor for human follicular B cell lymphoma. J Exp Med. 1992 Feb 1;175(2):371–376. doi: 10.1084/jem.175.2.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Cluitmans F. H., Esendam B. H., Landegent J. E., Willemze R., Falkenburg J. H. IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes. Ann Hematol. 1994 Jun;68(6):293–298. doi: 10.1007/BF01695035. [DOI] [PubMed] [Google Scholar]
  36. Combadiere C., Ahuja S. K., Van Damme J., Tiffany H. L., Gao J. L., Murphy P. M. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem. 1995 Dec 15;270(50):29671–29675. doi: 10.1074/jbc.270.50.29671. [DOI] [PubMed] [Google Scholar]
  37. Cousens L. P., Orange J. S., Su H. C., Biron C. A. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):634–639. doi: 10.1073/pnas.94.2.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Crowe P. D., VanArsdale T. L., Walter B. N., Ware C. F., Hession C., Ehrenfels B., Browning J. L., Din W. S., Goodwin R. G., Smith C. A. A lymphotoxin-beta-specific receptor. Science. 1994 Apr 29;264(5159):707–710. doi: 10.1126/science.8171323. [DOI] [PubMed] [Google Scholar]
  39. D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993 Sep 1;178(3):1041–1048. doi: 10.1084/jem.178.3.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Daig R., Andus T., Aschenbrenner E., Falk W., Schölmerich J., Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut. 1996 Feb;38(2):216–222. doi: 10.1136/gut.38.2.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Dale D. C., Liles W. C., Summer W. R., Nelson S. Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases. J Infect Dis. 1995 Oct;172(4):1061–1075. doi: 10.1093/infdis/172.4.1061. [DOI] [PubMed] [Google Scholar]
  42. Dalrymple S. A., Lucian L. A., Slattery R., McNeil T., Aud D. M., Fuchino S., Lee F., Murray R. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun. 1995 Jun;63(6):2262–2268. doi: 10.1128/iai.63.6.2262-2268.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Dalrymple S. A., Slattery R., Aud D. M., Krishna M., Lucian L. A., Murray R. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun. 1996 Aug;64(8):3231–3235. doi: 10.1128/iai.64.8.3231-3235.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Dayer J. M., Burger D. Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Netw. 1994 Nov-Dec;5(6):563–571. [PubMed] [Google Scholar]
  45. Defrance T., Carayon P., Billian G., Guillemot J. C., Minty A., Caput D., Ferrara P. Interleukin 13 is a B cell stimulating factor. J Exp Med. 1994 Jan 1;179(1):135–143. doi: 10.1084/jem.179.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Devergne O., Hummel M., Koeppen H., Le Beau M. M., Nathanson E. C., Kieff E., Birkenbach M. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol. 1996 Feb;70(2):1143–1153. doi: 10.1128/jvi.70.2.1143-1153.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Di Santo J. P., Kühn R., Müller W. Common cytokine receptor gamma chain (gamma c)-dependent cytokines: understanding in vivo functions by gene targeting. Immunol Rev. 1995 Dec;148:19–34. doi: 10.1111/j.1600-065x.1995.tb00091.x. [DOI] [PubMed] [Google Scholar]
  48. Dinarello C. A. Interleukin-1 and interleukin-1 receptor antagonist. Nutrition. 1995 Sep-Oct;11(5 Suppl):492–494. [PubMed] [Google Scholar]
  49. Dinarello C. A. Interleukin-1 antagonists. J Interferon Res. 1994 Oct;14(5):307–307. doi: 10.1089/jir.1994.14.307. [DOI] [PubMed] [Google Scholar]
  50. Dinarello C. A. The biological properties of interleukin-1. Eur Cytokine Netw. 1994 Nov-Dec;5(6):517–531. [PubMed] [Google Scholar]
  51. Dinarello C. A. The interleukin-1 family: 10 years of discovery. FASEB J. 1994 Dec;8(15):1314–1325. [PubMed] [Google Scholar]
  52. Dinarello C. A., Wolff S. M. The role of interleukin-1 in disease. N Engl J Med. 1993 Jan 14;328(2):106–113. doi: 10.1056/NEJM199301143280207. [DOI] [PubMed] [Google Scholar]
  53. Dittmar M. T., McKnight A., Simmons G., Clapham P. R., Weiss R. A., Simmonds P. HIV-1 tropism and co-receptor use. Nature. 1997 Feb 6;385(6616):495–496. doi: 10.1038/385495a0. [DOI] [PubMed] [Google Scholar]
  54. Doherty T. M., Seder R. A., Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol. 1996 Jan 15;156(2):735–741. [PubMed] [Google Scholar]
  55. Dunkley M. L., Husband A. J. The role of non-B cells in localizing an IgA plasma cell response in the intestine. Reg Immunol. 1990;3(6):336–340. [PubMed] [Google Scholar]
  56. Ertel W., Keel M., Steckholzer U., Ungethüm U., Trentz O. Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. Arch Surg. 1996 Jan;131(1):51–56. doi: 10.1001/archsurg.1996.01430130053009. [DOI] [PubMed] [Google Scholar]
  57. Eugster H. P., Muller M., Karrer U., Car B. D., Schnyder B., Eng V. M., Woerly G., Le Hir M., di Padova F., Aguet M. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int Immunol. 1996 Jan;8(1):23–36. doi: 10.1093/intimm/8.1.23. [DOI] [PubMed] [Google Scholar]
  58. Falus A. Cytokine receptor architecture, structure and genetic assembly. Immunol Lett. 1995 Jan;44(2-3):221–223. doi: 10.1016/0165-2478(95)00218-t. [DOI] [PubMed] [Google Scholar]
  59. Farrar M. A., Schreiber R. D. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol. 1993;11:571–611. doi: 10.1146/annurev.iy.11.040193.003035. [DOI] [PubMed] [Google Scholar]
  60. Fauci A. S. Host factors and the pathogenesis of HIV-induced disease. Nature. 1996 Dec 12;384(6609):529–534. doi: 10.1038/384529a0. [DOI] [PubMed] [Google Scholar]
  61. Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989 Dec 1;170(6):2081–2095. doi: 10.1084/jem.170.6.2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Fleming S. D., Campbell P. A. Macrophages have cell surface IL-10 that regulates macrophage bactericidal activity. J Immunol. 1996 Feb 1;156(3):1143–1150. [PubMed] [Google Scholar]
  63. Gallagher R. Tagging T cells: TH1 or TH2? Science. 1997 Mar 14;275(5306):1615–1615. doi: 10.1126/science.275.5306.1615. [DOI] [PubMed] [Google Scholar]
  64. Ganser A., Völkers B., Greher J., Ottmann O. G., Walther F., Becher R., Bergmann L., Schulz G., Hoelzer D. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial. Blood. 1989 Jan;73(1):31–37. [PubMed] [Google Scholar]
  65. Garcia-Zepeda E. A., Combadiere C., Rothenberg M. E., Sarafi M. N., Lavigne F., Hamid Q., Murphy P. M., Luster A. D. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol. 1996 Dec 15;157(12):5613–5626. [PubMed] [Google Scholar]
  66. Gasperini S., Calzetti F., Russo M. P., De Gironcoli M., Cassatella M. A. Regulation of GRO alpha production in human granulocytes. J Inflamm. 1995;45(3):143–151. [PubMed] [Google Scholar]
  67. Geist L. J., Hunninghake G. W. Cytokine gene regulation by viral gene products. J Lab Clin Med. 1995 Dec;126(6):517–520. [PubMed] [Google Scholar]
  68. Giri J. G., Anderson D. M., Kumaki S., Park L. S., Grabstein K. H., Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol. 1995 May;57(5):763–766. doi: 10.1002/jlb.57.5.763. [DOI] [PubMed] [Google Scholar]
  69. Gleich G. J., Adolphson C. R. The eosinophilic leukocyte: structure and function. Adv Immunol. 1986;39:177–253. doi: 10.1016/s0065-2776(08)60351-x. [DOI] [PubMed] [Google Scholar]
  70. Glickstein L. J., Huber B. T. Karoushi--death by overwork in the immune system. J Immunol. 1995 Jul 15;155(2):522–524. [PubMed] [Google Scholar]
  71. Gordon M. S., McCaskill-Stevens W. J., Battiato L. A., Loewy J., Loesch D., Breeden E., Hoffman R., Beach K. J., Kuca B., Kaye J. A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood. 1996 May 1;87(9):3615–3624. [PubMed] [Google Scholar]
  72. Gordon M. S. Thrombopoietic activity of recombinant human interleukin 11 in cancer patients receiving chemotherapy. Cancer Chemother Pharmacol. 1996;38 (Suppl):S96–S98. doi: 10.1007/s002800051047. [DOI] [PubMed] [Google Scholar]
  73. Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994 May 13;264(5161):965–968. doi: 10.1126/science.8178155. [DOI] [PubMed] [Google Scholar]
  74. Grell M., Douni E., Wajant H., Löhden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 1995 Dec 1;83(5):793–802. doi: 10.1016/0092-8674(95)90192-2. [DOI] [PubMed] [Google Scholar]
  75. Grimm M. C., Elsbury S. K., Pavli P., Doe W. F. Interleukin 8: cells of origin in inflammatory bowel disease. Gut. 1996 Jan;38(1):90–98. doi: 10.1136/gut.38.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Groopman J. E., Molina J. M., Scadden D. T. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med. 1989 Nov 23;321(21):1449–1459. doi: 10.1056/NEJM198911233212106. [DOI] [PubMed] [Google Scholar]
  77. Gruss H. J., Dower S. K. The TNF ligand superfamily and its relevance for human diseases. Cytokines Mol Ther. 1995 Jun;1(2):75–105. [PubMed] [Google Scholar]
  78. Hansen M. B., Svenson M., Diamant M., Abell K., Bendtzen K. Interleukin-6 autoantibodies: possible biological and clinical significance. Leukemia. 1995 Jul;9(7):1113–1115. [PubMed] [Google Scholar]
  79. Hauser S. L. Tumor necrosis factor: immunogenetics and disease. Ann Neurol. 1995 Nov;38(5):702–704. doi: 10.1002/ana.410380503. [DOI] [PubMed] [Google Scholar]
  80. He Y. W., Adkins B., Furse R. K., Malek T. R. Expression and function of the gamma c subunit of the IL-2, IL-4, and IL-7 receptors. Distinct interaction of gamma c in the IL-4 receptor. J Immunol. 1995 Feb 15;154(4):1596–1605. [PubMed] [Google Scholar]
  81. Heaney M. L., Golde D. W. Soluble cytokine receptors. Blood. 1996 Feb 1;87(3):847–857. [PubMed] [Google Scholar]
  82. Heldin C. H. Structural and functional studies on platelet-derived growth factor. EMBO J. 1992 Dec;11(12):4251–4259. doi: 10.1002/j.1460-2075.1992.tb05523.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Hendrzak J. A., Brunda M. J. Interleukin-12. Biologic activity, therapeutic utility, and role in disease. Lab Invest. 1995 Jun;72(6):619–637. [PubMed] [Google Scholar]
  84. Herrod H. G. Interleukins in immunologic and allergic diseases. Ann Allergy. 1989 Oct;63(4):269–272. [PubMed] [Google Scholar]
  85. Hibi M., Nakajima K., Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med (Berl) 1996 Jan;74(1):1–12. doi: 10.1007/BF00202068. [DOI] [PubMed] [Google Scholar]
  86. Hirao T., Aoki H., Ichikawa H., Sato Y. Characterization of an interleukin 1 receptor antagonist protein released from ultraviolet-irradiated epidermal sheet. J Dermatol Sci. 1997 Mar;14(3):189–198. doi: 10.1016/s0923-1811(96)00572-5. [DOI] [PubMed] [Google Scholar]
  87. Horak I., Löhler J., Ma A., Smith K. A. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev. 1995 Dec;148:35–44. doi: 10.1111/j.1600-065x.1995.tb00092.x. [DOI] [PubMed] [Google Scholar]
  88. Howard M., Farrar J., Hilfiker M., Johnson B., Takatsu K., Hamaoka T., Paul W. E. Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med. 1982 Mar 1;155(3):914–923. doi: 10.1084/jem.155.3.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Huhn R. D., Radwanski E., O'Connell S. M., Sturgill M. G., Clarke L., Cody R. P., Affrime M. B., Cutler D. L. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood. 1996 Jan 15;87(2):699–705. [PubMed] [Google Scholar]
  90. Idzerda R. L., March C. J., Mosley B., Lyman S. D., Vanden Bos T., Gimpel S. D., Din W. S., Grabstein K. H., Widmer M. B., Park L. S. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med. 1990 Mar 1;171(3):861–873. doi: 10.1084/jem.171.3.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Thierfelder W. E., Kreider B., Silvennoinen O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci. 1994 May;19(5):222–227. doi: 10.1016/0968-0004(94)90026-4. [DOI] [PubMed] [Google Scholar]
  92. Jameson S. C., Bevan M. J. T cell receptor antagonists and partial agonists. Immunity. 1995 Jan;2(1):1–11. doi: 10.1016/1074-7613(95)90074-8. [DOI] [PubMed] [Google Scholar]
  93. Joyce D. A., Steer J. H. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes. Cytokine. 1996 Jan;8(1):49–57. doi: 10.1006/cyto.1996.0007. [DOI] [PubMed] [Google Scholar]
  94. Jullien D., Sieling P. A., Uyemura K., Mar N. D., Rea T. H., Modlin R. L. IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol. 1997 Jan 15;158(2):800–806. [PubMed] [Google Scholar]
  95. Karnitz L. M., Abraham R. T. Cytokine receptor signaling mechanisms. Curr Opin Immunol. 1995 Jun;7(3):320–326. doi: 10.1016/0952-7915(95)80105-7. [DOI] [PubMed] [Google Scholar]
  96. Kato T., Morokata T., Igarashi O., Yee S. T., Inobe M., Uede T., Azuma M., Okumura K., Nariuchi H. Costimulatory effect of IL-12 on the activation of naive, memory CD4+ T cells, and Th1 clone. Cell Immunol. 1997 Feb 25;176(1):50–58. doi: 10.1006/cimm.1996.1072. [DOI] [PubMed] [Google Scholar]
  97. Kawashima I., Takiguchi Y. Interleukin-11: a novel stroma-derived cytokine. Prog Growth Factor Res. 1992;4(3):191–206. doi: 10.1016/0955-2235(92)90019-e. [DOI] [PubMed] [Google Scholar]
  98. Kelner G. S., Kennedy J., Bacon K. B., Kleyensteuber S., Largaespada D. A., Jenkins N. A., Copeland N. G., Bazan J. F., Moore K. W., Schall T. J. Lymphotactin: a cytokine that represents a new class of chemokine. Science. 1994 Nov 25;266(5189):1395–1399. doi: 10.1126/science.7973732. [DOI] [PubMed] [Google Scholar]
  99. Kim C., Schinkel C., Fuchs D., Stadler J., Walz A., Zedler S., von Donnersmarck G. H., Faist E. Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch Surg. 1995 Dec;130(12):1330–1336. doi: 10.1001/archsurg.1995.01430120084013. [DOI] [PubMed] [Google Scholar]
  100. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood. 1995 Aug 15;86(4):1243–1254. [PubMed] [Google Scholar]
  101. Kishimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992 Oct 23;258(5082):593–597. doi: 10.1126/science.1411569. [DOI] [PubMed] [Google Scholar]
  102. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 1994 Jan 28;76(2):253–262. doi: 10.1016/0092-8674(94)90333-6. [DOI] [PubMed] [Google Scholar]
  103. Knall C., Young S., Nick J. A., Buhl A. M., Worthen G. S., Johnson G. L. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem. 1996 Feb 2;271(5):2832–2838. doi: 10.1074/jbc.271.5.2832. [DOI] [PubMed] [Google Scholar]
  104. Komschlies K. L., Grzegorzewski K. J., Wiltrout R. H. Diverse immunological and hematological effects of interleukin 7: implications for clinical application. J Leukoc Biol. 1995 Dec;58(6):623–633. doi: 10.1002/jlb.58.6.623. [DOI] [PubMed] [Google Scholar]
  105. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994 Mar 24;368(6469):339–342. doi: 10.1038/368339a0. [DOI] [PubMed] [Google Scholar]
  106. Kopf M., Le Gros G., Coyle A. J., Kosco-Vilbois M., Brombacher F. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol Rev. 1995 Dec;148:45–69. doi: 10.1111/j.1600-065x.1995.tb00093.x. [DOI] [PubMed] [Google Scholar]
  107. Kosugi H., Nakagawa Y., Arai K., Yokota T. Gene structures of the alpha subunits of human IL-3 and granulocyte-macrophage colony-stimulating factor receptors: comparison with the cytokine receptor superfamily. J Allergy Clin Immunol. 1995 Dec;96(6 Pt 2):1115–1125. doi: 10.1016/s0091-6749(95)70196-6. [DOI] [PubMed] [Google Scholar]
  108. Kunimoto D. Y., Nordan R. P., Strober W. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J Immunol. 1989 Oct 1;143(7):2230–2235. [PubMed] [Google Scholar]
  109. Kunkel S. L., Lukacs N., Strieter R. M. Expression and biology of neutrophil and endothelial cell-derived chemokines. Semin Cell Biol. 1995 Dec;6(6):327–336. doi: 10.1016/s1043-4682(05)80003-0. [DOI] [PubMed] [Google Scholar]
  110. Kurzrock R., Wetzler M., Estrov Z., Talpaz M. Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias. Cytokines Mol Ther. 1995 Sep;1(3):177–184. [PubMed] [Google Scholar]
  111. Laberge S., Cruikshank W. W., Beer D. J., Center D. M. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol. 1996 Jan 1;156(1):310–315. [PubMed] [Google Scholar]
  112. Lee J. D., Rhoades K., Economou J. S. Interleukin-4 inhibits the expression of tumour necrosis factors alpha and beta, interleukins-1 beta and -6 and interferon-gamma. Immunol Cell Biol. 1995 Feb;73(1):57–61. doi: 10.1038/icb.1995.9. [DOI] [PubMed] [Google Scholar]
  113. Lemmel E. M., Brackertz D., Franke M., Gaus W., Hartl P. W., Machalke K., Mielke H., Obert H. J., Peter H. H., Sieper J. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol Int. 1988;8(2):87–93. doi: 10.1007/BF00271840. [DOI] [PubMed] [Google Scholar]
  114. Leonard W. J., Shores E. W., Love P. E. Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol Rev. 1995 Dec;148:97–114. doi: 10.1111/j.1600-065x.1995.tb00095.x. [DOI] [PubMed] [Google Scholar]
  115. Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N Engl J Med. 1992 Jul 9;327(2):99–106. doi: 10.1056/NEJM199207093270207. [DOI] [PubMed] [Google Scholar]
  116. Lieschke G. J., Maher D., Cebon J., O'Connor M., Green M., Sheridan W., Boyd A., Rallings M., Bonnem E., Metcalf D. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Ann Intern Med. 1989 Mar 1;110(5):357–364. doi: 10.7326/0003-4819-110-5-357. [DOI] [PubMed] [Google Scholar]
  117. Liles W. C., Van Voorhis W. C. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis. 1995 Dec;172(6):1573–1580. doi: 10.1093/infdis/172.6.1573. [DOI] [PubMed] [Google Scholar]
  118. Lin R., Tarr P. E., Jones T. C. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin Infect Dis. 1995 Dec;21(6):1439–1449. doi: 10.1093/clinids/21.6.1439. [DOI] [PubMed] [Google Scholar]
  119. Lindemann A., Mertelsmann R. Interleukin-3: structure and function. Cancer Invest. 1993;11(5):609–623. doi: 10.3109/07357909309011680. [DOI] [PubMed] [Google Scholar]
  120. Locksley R. M. Interleukin 12 in host defense against microbial pathogens. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5879–5880. doi: 10.1073/pnas.90.13.5879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Lucey D. R., Clerici M., Shearer G. M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev. 1996 Oct;9(4):532–562. doi: 10.1128/cmr.9.4.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. McCartney-Francis N. L., Wahl S. M. Transforming growth factor beta: a matter of life and death. J Leukoc Biol. 1994 Mar;55(3):401–409. doi: 10.1002/jlb.55.3.401. [DOI] [PubMed] [Google Scholar]
  123. McInnes I. B., al-Mughales J., Field M., Leung B. P., Huang F. P., Dixon R., Sturrock R. D., Wilkinson P. C., Liew F. Y. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med. 1996 Feb;2(2):175–182. doi: 10.1038/nm0296-175. [DOI] [PubMed] [Google Scholar]
  124. McMillen M. A., Sumpio B. E. Endothelins: polyfunctional cytokines. J Am Coll Surg. 1995 May;180(5):621–637. [PubMed] [Google Scholar]
  125. Mehler M. F., Rozental R., Dougherty M., Spray D. C., Kessler J. A. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature. 1993 Mar 4;362(6415):62–65. doi: 10.1038/362062a0. [DOI] [PubMed] [Google Scholar]
  126. Merz H., Houssiau F. A., Orscheschek K., Renauld J. C., Fliedner A., Herin M., Noel H., Kadin M., Mueller-Hermelink H. K., Van Snick J. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood. 1991 Sep 1;78(5):1311–1317. [PubMed] [Google Scholar]
  127. Metcalf D. Leukemia inhibitory factor--a puzzling polyfunctional regulator. Growth Factors. 1992;7(3):169–173. doi: 10.3109/08977199209046921. [DOI] [PubMed] [Google Scholar]
  128. Micallef M. J., Ohtsuki T., Kohno K., Tanabe F., Ushio S., Namba M., Tanimoto T., Torigoe K., Fujii M., Ikeda M. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996 Jul;26(7):1647–1651. doi: 10.1002/eji.1830260736. [DOI] [PubMed] [Google Scholar]
  129. Miller D. K., Myerson J., Becker J. W. The interleukin-1 beta converting enzyme family of cysteine proteases. J Cell Biochem. 1997 Jan;64(1):2–10. doi: 10.1002/(sici)1097-4644(199701)64:1<2::aid-jcb2>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  130. Miller M. D., Krangel M. S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol. 1992;12(1-2):17–46. [PubMed] [Google Scholar]
  131. Minami Y., Kono T., Miyazaki T., Taniguchi T. The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol. 1993;11:245–268. doi: 10.1146/annurev.iy.11.040193.001333. [DOI] [PubMed] [Google Scholar]
  132. Minty A., Chalon P., Derocq J. M., Dumont X., Guillemot J. C., Kaghad M., Labit C., Leplatois P., Liauzun P., Miloux B. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 1993 Mar 18;362(6417):248–250. doi: 10.1038/362248a0. [DOI] [PubMed] [Google Scholar]
  133. Moore K. W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Annu Rev Immunol. 1993;11:165–190. doi: 10.1146/annurev.iy.11.040193.001121. [DOI] [PubMed] [Google Scholar]
  134. Mosmann T. R. Properties and functions of interleukin-10. Adv Immunol. 1994;56:1–26. [PubMed] [Google Scholar]
  135. Motoyoshi K. Macrophage colony-stimulating factor for cancer therapy. Oncology. 1994 Mar-Apr;51(2):198–204. doi: 10.1159/000227334. [DOI] [PubMed] [Google Scholar]
  136. Mukaida N., Harada A., Yasumoto K., Matsushima K. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol Immunol. 1992;36(8):773–789. doi: 10.1111/j.1348-0421.1992.tb02080.x. [DOI] [PubMed] [Google Scholar]
  137. Murata T., Noguchi P. D., Puri R. K. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J Biol Chem. 1995 Dec 22;270(51):30829–30836. doi: 10.1074/jbc.270.51.30829. [DOI] [PubMed] [Google Scholar]
  138. Murphy P. M. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994;12:593–633. doi: 10.1146/annurev.iy.12.040194.003113. [DOI] [PubMed] [Google Scholar]
  139. Muzio M., Polentarutti N., Sironi M., Poli G., De Gioia L., Introna M., Mantovani A., Colotta F. Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J Exp Med. 1995 Aug 1;182(2):623–628. doi: 10.1084/jem.182.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Nakano H., Oshima H., Chung W., Williams-Abbott L., Ware C. F., Yagita H., Okumura K. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J Biol Chem. 1996 Jun 21;271(25):14661–14664. doi: 10.1074/jbc.271.25.14661. [DOI] [PubMed] [Google Scholar]
  141. Namen A. E., Williams D. E., Goodwin R. G. Interleukin-7: a new hematopoietic growth factor. Prog Clin Biol Res. 1990;338:65–73. [PubMed] [Google Scholar]
  142. Neben S., Turner K. The biology of interleukin 11. Stem Cells. 1993 Jul;11 (Suppl 2):156–162. doi: 10.1002/stem.5530110825. [DOI] [PubMed] [Google Scholar]
  143. Nishimura H., Hiromatsu K., Kobayashi N., Grabstein K. H., Paxton R., Sugamura K., Bluestone J. A., Yoshikai Y. IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. J Immunol. 1996 Jan 15;156(2):663–669. [PubMed] [Google Scholar]
  144. O'Neill L. A. Interleukin-1 signal transduction. Int J Clin Lab Res. 1995;25(4):169–177. doi: 10.1007/BF02592694. [DOI] [PubMed] [Google Scholar]
  145. Obiri N. I., Leland P., Murata T., Debinski W., Puri R. K. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J Immunol. 1997 Jan 15;158(2):756–764. [PubMed] [Google Scholar]
  146. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995 Nov 2;378(6552):88–91. doi: 10.1038/378088a0. [DOI] [PubMed] [Google Scholar]
  147. Page L. A., Topp M. S., Thorpe R., Mire-Sluis A. R. An antiproliferative bioassay for interleukin-4. J Immunol Methods. 1996 Jan 16;189(1):129–135. doi: 10.1016/0022-1759(95)00245-6. [DOI] [PubMed] [Google Scholar]
  148. Parada N. A., Cruikshank W. W., Danis H. L., Ryan T. C., Center D. M. IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell Immunol. 1996 Feb 25;168(1):100–106. doi: 10.1006/cimm.1996.0054. [DOI] [PubMed] [Google Scholar]
  149. Paul W. E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 1991 May 1;77(9):1859–1870. [PubMed] [Google Scholar]
  150. Pfeilschifter J. Cytokines and signal transduction. Clin Investig. 1994 Sep;72(9):713–714. doi: 10.1007/BF00212999. [DOI] [PubMed] [Google Scholar]
  151. Poltorak A. N., Bazzoni F., Smirnova I. I., Alejos E., Thompson P., Luheshi G., Rothwell N., Beutler B. MIP-1 gamma: molecular cloning, expression, and biological activities of a novel CC chemokine that is constitutively secreted in vivo. J Inflamm. 1995;45(3):207–219. [PubMed] [Google Scholar]
  152. Ponzoni M., Casalaro A., Lanciotti M., Montaldo P. G., Cornaglia-Ferraris P. The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res. 1992 Feb 15;52(4):931–939. [PubMed] [Google Scholar]
  153. Proost P., Wuyts A., Van Damme J. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol. 1996 Jan;59(1):67–74. doi: 10.1002/jlb.59.1.67. [DOI] [PubMed] [Google Scholar]
  154. Renauld J. C., Houssiau F., Louahed J., Vink A., Van Snick J., Uyttenhove C. Interleukin-9. Adv Immunol. 1993;54:79–97. doi: 10.1016/s0065-2776(08)60533-7. [DOI] [PubMed] [Google Scholar]
  155. Richards C. D., Langdon C., Pennica D., Gauldie J. Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. J Interferon Cytokine Res. 1996 Jan;16(1):69–75. doi: 10.1089/jir.1996.16.69. [DOI] [PubMed] [Google Scholar]
  156. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D. H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med. 1997 Mar 3;185(5):825–831. doi: 10.1084/jem.185.5.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Romani L., Mencacci A., Cenci E., Spaccapelo R., Toniatti C., Puccetti P., Bistoni F., Poli V. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med. 1996 Apr 1;183(4):1345–1355. doi: 10.1084/jem.183.4.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Ross R., Raines E. W., Bowen-Pope D. F. The biology of platelet-derived growth factor. Cell. 1986 Jul 18;46(2):155–169. doi: 10.1016/0092-8674(86)90733-6. [DOI] [PubMed] [Google Scholar]
  159. Roth S. J., Carr M. W., Springer T. A. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol. 1995 Dec;25(12):3482–3488. doi: 10.1002/eji.1830251241. [DOI] [PubMed] [Google Scholar]
  160. Russell S. M., Keegan A. D., Harada N., Nakamura Y., Noguchi M., Leland P., Friedmann M. C., Miyajima A., Puri R. K., Paul W. E. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science. 1993 Dec 17;262(5141):1880–1883. doi: 10.1126/science.8266078. [DOI] [PubMed] [Google Scholar]
  161. Ryffel B. Gene knockout mice as investigative tools in pathophysiology. Int J Exp Pathol. 1996 Aug;77(4):125–141. doi: 10.1046/j.1365-2613.1996.d01-215.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Sanderson C. J., Campbell H. D., Young I. G. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol Rev. 1988 Feb;102:29–50. doi: 10.1111/j.1600-065x.1988.tb00740.x. [DOI] [PubMed] [Google Scholar]
  163. Schall T. J. Biology of the RANTES/SIS cytokine family. Cytokine. 1991 May;3(3):165–183. doi: 10.1016/1043-4666(91)90013-4. [DOI] [PubMed] [Google Scholar]
  164. Schindler C. Cytokine signal transduction. Receptor. 1995 Spring;5(1):51–62. [PubMed] [Google Scholar]
  165. Sechler J. M., Malech H. L., White C. J., Gallin J. I. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4874–4878. doi: 10.1073/pnas.85.13.4874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Sengupta T. K., Schmitt E. M., Ivashkiv L. B. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9499–9504. doi: 10.1073/pnas.93.18.9499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Sharma S., Mehta S., Morgan J., Maizel A. Molecular cloning and expression of a human B-cell growth factor gene in Escherichia coli. Science. 1987 Mar 20;235(4795):1489–1492. doi: 10.1126/science.3547651. [DOI] [PubMed] [Google Scholar]
  168. Sims J. E., Dower S. K. Interleukin-1 receptors. Eur Cytokine Netw. 1994 Nov-Dec;5(6):539–546. [PubMed] [Google Scholar]
  169. Sims J. E., Gayle M. A., Slack J. L., Alderson M. R., Bird T. A., Giri J. G., Colotta F., Re F., Mantovani A., Shanebeck K. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6155–6159. doi: 10.1073/pnas.90.13.6155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Sosroseno W., Herminajeng E. The immunoregulatory roles of transforming growth factor beta. Br J Biomed Sci. 1995 Jun;52(2):142–148. [PubMed] [Google Scholar]
  171. Stern A. S., Magram J., Presky D. H. Interleukin-12 an integral cytokine in the immune response. Life Sci. 1996;58(8):639–654. doi: 10.1016/s0024-3205(96)80003-8. [DOI] [PubMed] [Google Scholar]
  172. Sugamura K., Asao H., Kondo M., Tanaka N., Ishii N., Ohbo K., Nakamura M., Takeshita T. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol. 1996;14:179–205. doi: 10.1146/annurev.immunol.14.1.179. [DOI] [PubMed] [Google Scholar]
  173. Tafuto S., Silvestri I., D'Andrea P., Ronga D., Abate G. Interleukin-6: biological features and clinical implications. J Biol Regul Homeost Agents. 1994 Jan-Mar;8(1):1–8. [PubMed] [Google Scholar]
  174. Tai P. C., Ackerman S. J., Spry C. J., Dunnette S., Olsen E. G., Gleich G. J. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet. 1987 Mar 21;1(8534):643–647. doi: 10.1016/s0140-6736(87)90412-0. [DOI] [PubMed] [Google Scholar]
  175. Takatsu K., Tominaga A., Harada N., Mita S., Matsumoto M., Takahashi T., Kikuchi Y., Yamaguchi N. T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol Rev. 1988 Feb;102:107–135. doi: 10.1111/j.1600-065x.1988.tb00743.x. [DOI] [PubMed] [Google Scholar]
  176. Taub D. D., Lloyd A. R., Conlon K., Wang J. M., Ortaldo J. R., Harada A., Matsushima K., Kelvin D. J., Oppenheim J. J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993 Jun 1;177(6):1809–1814. doi: 10.1084/jem.177.6.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Taub D. D., Ortaldo J. R., Turcovski-Corrales S. M., Key M. L., Longo D. L., Murphy W. J. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol. 1996 Jan;59(1):81–89. doi: 10.1002/jlb.59.1.81. [DOI] [PubMed] [Google Scholar]
  178. Thornberry N. A. Interleukin-1 beta converting enzyme. Methods Enzymol. 1994;244:615–631. doi: 10.1016/0076-6879(94)44045-x. [DOI] [PubMed] [Google Scholar]
  179. Tracey K. J., Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol. 1993;9:317–343. doi: 10.1146/annurev.cb.09.110193.001533. [DOI] [PubMed] [Google Scholar]
  180. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today. 1993 Jul;14(7):335–338. doi: 10.1016/0167-5699(93)90230-I. [DOI] [PubMed] [Google Scholar]
  181. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994 Dec 15;84(12):4008–4027. [PubMed] [Google Scholar]
  182. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990;8:253–278. doi: 10.1146/annurev.iy.08.040190.001345. [DOI] [PubMed] [Google Scholar]
  183. Van Vlasselaer P. Leukemia inhibitory factor (LIF): a growth factor with pleiotropic effects on bone biology. Prog Growth Factor Res. 1992;4(4):337–353. doi: 10.1016/0955-2235(92)90015-a. [DOI] [PubMed] [Google Scholar]
  184. Viale G., Vercelli D. Interleukin-13 regulates the phenotype and function of human monocytes. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):176–178. doi: 10.1159/000236969. [DOI] [PubMed] [Google Scholar]
  185. Vilcek J., Lee T. H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 1991 Apr 25;266(12):7313–7316. [PubMed] [Google Scholar]
  186. Vogels M. T., Lindley I. J., Curfs J. H., Eling W. M., van der Meer J. W. Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob Agents Chemother. 1993 Feb;37(2):276–280. doi: 10.1128/aac.37.2.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Wang W., Chen H. J., Giedd K. N., Schwartz A., Cannon P. J., Rabbani L. E. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor. Circ Res. 1995 Dec;77(6):1095–1106. doi: 10.1161/01.res.77.6.1095. [DOI] [PubMed] [Google Scholar]
  188. Watkins L. R., Maier S. F., Goehler L. E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995 Dec;63(3):289–302. doi: 10.1016/0304-3959(95)00186-7. [DOI] [PubMed] [Google Scholar]
  189. Weber-Nordt R. M., Henschler R., Schott E., Wehinger J., Behringer D., Mertelsmann R., Finke J. Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood. 1996 Oct 1;88(7):2549–2558. [PubMed] [Google Scholar]
  190. Weiergräber O., Hemmann U., Küster A., Müller-Newen G., Schneider J., Rose-John S., Kurschat P., Brakenhoff J. P., Hart M. H., Stabel S. Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization. Eur J Biochem. 1995 Dec 1;234(2):661–669. doi: 10.1111/j.1432-1033.1995.661_b.x. [DOI] [PubMed] [Google Scholar]
  191. Weiss T., Grell M., Hessabi B., Bourteele S., Müller G., Scheurich P., Wajant H. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J Immunol. 1997 Mar 1;158(5):2398–2404. [PubMed] [Google Scholar]
  192. Wells J. A. Binding in the growth hormone receptor complex. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):1–6. doi: 10.1073/pnas.93.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Wells T. N., Power C. A., Lusti-Narasimhan M., Hoogewerf A. J., Cooke R. M., Chung C. W., Peitsch M. C., Proudfoot A. E. Selectivity and antagonism of chemokine receptors. J Leukoc Biol. 1996 Jan;59(1):53–60. doi: 10.1002/jlb.59.1.53. [DOI] [PubMed] [Google Scholar]
  194. Williams D. E., de Vries P., Namen A. E., Widmer M. B., Lyman S. D. The Steel factor. Dev Biol. 1992 Jun;151(2):368–376. doi: 10.1016/0012-1606(92)90176-h. [DOI] [PubMed] [Google Scholar]
  195. Yao Z., Fanslow W. C., Seldin M. F., Rousseau A. M., Painter S. L., Comeau M. R., Cohen J. I., Spriggs M. K. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995 Dec;3(6):811–821. doi: 10.1016/1074-7613(95)90070-5. [DOI] [PubMed] [Google Scholar]
  196. Yao Z., Painter S. L., Fanslow W. C., Ulrich D., Macduff B. M., Spriggs M. K., Armitage R. J. Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995 Dec 15;155(12):5483–5486. [PubMed] [Google Scholar]
  197. Yoshimoto T., Kojima K., Funakoshi T., Endo Y., Fujita T., Nariuchi H. Molecular cloning and characterization of murine IL-12 genes. J Immunol. 1996 Feb 1;156(3):1082–1088. [PubMed] [Google Scholar]
  198. Zhao Y. X., Tarkowski A. Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol. 1995 Dec 15;155(12):5736–5742. [PubMed] [Google Scholar]
  199. de Jong J. L., Farner N. L., Widmer M. B., Giri J. G., Sondel P. M. Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex. J Immunol. 1996 Feb 15;156(4):1339–1348. [PubMed] [Google Scholar]
  200. de Waal Malefyt R., Figdor C. G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J. E. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol. 1993 Dec 1;151(11):6370–6381. [PubMed] [Google Scholar]
  201. van der Meer J. W., Vogels M., Curfs J. H., Eling W. M. Interleukin-1 as a possible agent for treatment of infection. Eur J Clin Microbiol Infect Dis. 1993;12 (Suppl 1):S73–S77. doi: 10.1007/BF02389883. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES